Healthcare Industry Insights: July 2023

Wednesday 26 July 2023

Pneumatic Tourniquet Market Size Worth $591.6 Million By 2028

The global Pneumatic Tourniquet Market size is expected to reach USD 591.6 million by 2028, registering a CAGR of 7.0% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of orthopedic and plastic surgeries performed is driving the growth of this market. Moreover, a surge in accidental injuries further contributes to the growth of the market. For instance, according to the Association for Safe International Road Travel (ASIRT), around 38,000 people die and an additional 4.4 million are severely injured annually in crashes on U.S. roadways.

Thus, the demand for pneumatic tourniquets is predicted to increase, as they are mainly used to control bleeding in emergency situations, such as accidents. Furthermore, increasing private and public expenses on the development of healthcare infrastructure in emerging economies are propelling the market growth. In addition, rising R&D activities to develop advanced products are likely to create lucrative market growth opportunities.

Tourniquets are widely used in hospitals for orthopedic procedures if external hemorrhage cannot be controlled by direct pressure. Furthermore, these systems are extensively used owing to their ability to create a bloodless field during orthopedic surgery. This helps surgeons to reduce procedural time. Moreover, the device is used for urgent management of breathing and airway issues during emergencies, such as severe limb amputation or limb hemorrhages with multiple bleeding points. It also offers greater flexibility and reliability, leading to the rising product demand.

List of Key Players of Pneumatic Tourniquet Market

Zimmer Biomet
Stryker
Ulrich Medical
VBM
Anetic Aid
DSMAREF Co. Ltd.

Related Press Release@ Pneumatic Tourniquet Market Report

Pneumatic Tourniquet Market Report Highlights

In terms of type, the single-bladder segment held the largest market share of over 66% in 2020
The growth is attributed to the high demand for single-bladder devices due to the better clinical efficacy offered by them
In terms of application, the others segment held the largest market share in 2020
The segment is expected to remain dominant growing at a considerable growth rate over the forecast period
Asia Pacific market is expected to witness the fastest growth rate over the forecast period
This growth is credited to the rising number of orthopedic surgeries performed and growing cases of accidental injuries

Related Reports@

Pneumatic Conveying Systems Market

Pneumatic Nebulizers Market

Pneumatic Tourniquet Market Segmentation

Grand View Research has segmented the global pneumatic tourniquet market on the basis of type, application, and region:

Pneumatic Tourniquet Type Outlook (Revenue, USD Million, 2016 - 2028)

Single-bladder
Double-bladder

Pneumatic Tourniquet Application Outlook (Revenue, USD Million, 2016 - 2028)

Orthopedic
Intravenous Regional Anesthesia (IVRA)
Others

Pneumatic Tourniquet Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

U.S.
Canada

Europe

U.K.
Germany

Asia Pacific

Japan
China

Latin America

Brazil
Mexico

South Africa
Saudi Arabia

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Clinical Trial Kits Market Size is Predicted to Witness 8.5% CAGR till 2028

The global Clinical Trial Kits Market size is anticipated to reach USD 2.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.

Remote clinical trial services are becoming increasingly essential in terms of patient retention, satisfaction, and safety. To enhance their capabilities, pharmaceutical companies have created a relationship with global logistics partners to provide direct-to-patient services. These services provide participants with the flexibility and convenience of participating in the trials while remaining at home.

COVID-19 pandemic has affected the market which resulted in slowing down the trial process. The COVID-19 pandemic is rapidly boosting advances in medical practices that allow people to connect with the healthcare system remotely. This effort of examining the patients at their homes has raised interest in at-home sample collection and testing. Such services offer convenience and minimize potential exposure to SARS-CoV-2.

Companies began to move to provide direct-to-consumer testing digital services. More aspects of the testing process, from test ordering to sample collection, are already making their way into patients' homes. Besides, regulatory authorities have instantly given sponsors guidelines to resolve issues that have arisen during ongoing clinical studies. Changes such as the use of telemedicine, the elimination of non-essential visits and laboratory assessments, as well as diagnostic testing and sample collection, have allowed many studies to continue while ensuring patient safety during the pandemic.

Related Press Release@ Clinical Trial Kits Market Report

List of Key Players of Clinical Trial Kits Market

Brooks life science
Q2 solutions
Patheon (Thermo fisher scientific)
LabCorp drug development
Charles river laboratories
LabConnect
Almac group
Precision medicine group
Cerba research
Alpha laboratories
Marken
Clinigen

Clinical Trial Kits Market Report Highlights

The logistics segment dominated the market and accounted for the largest revenue share of 54.9% in 2020. This is due to the increasing demand for services to simplify the logistics process in clinical trials
The phase III segment dominated the market and accounted for the largest revenue share of 53.4% in 2020 as phase III trials require a large number of participants
North America dominated the market in 2020 owing to favorable government support and the existence of a large number of companies offering innovative services in the U.S.
In Asia Pacific, the market is projected to witness the highest CAGR of 9.9% over the forecast period as the region is continuously growing in terms of clinical trials due to the vast population and developing technology

Related Reports@

Clinical Laboratory Tests Market

Clinical Microbiology Market

Clinical Trial Kits Market Segmentation

Grand View Research has segmented the global clinical trial kits market on the basis of service, phase, and region:

Clinical Trials Kits Service Outlook (Revenue, USD Million, 2016 - 2028)

Kitting Solutions
Drugs kits
Sample collection kits
Logistics
Transportation
Warehousing & Storage
Others

Clinical Trial Kits Phase Outlook (Revenue, USD Million, 2016 - 2028)

Phase I
Phase II
Phase III
Phase IV

Clinical Trial Kits Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

U.S.
Canada

Europe

Germany
U.K.
France
Italy
Spain

Asia Pacific

China
Japan
India
South Korea
Australia

Latin America

Mexico
Brazil
Argentina
Colombia

South Africa
Saudi Arabia
UAE

Tuesday 25 July 2023

Veterinary Antimicrobial Susceptibility Testing Market – Industry Insights by Product And End-use

The global Veterinary Antimicrobial Susceptibility Testing Market size is expected to reach USD 52.78 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.1% from 2021 to 2028. The key factors fueling the market growth include growing demand for livestock products and increasing government initiatives.

Government initiatives mandating safe healthcare practices for livestock and companion animals are fueling the growth of the market. Several governments worldwide are focused on protecting animals and humans from antibiotics resistance. In addition, efforts are being taken to increase awareness about the reduction of usage of antimicrobials in food animals. The WHO is collaborating with the World Organization for Animal Health (OIE), Food and Agriculture Organization (FAO), national ministries of health, World Bank, and UNSIC to take major actions regarding antimicrobial resistance, which is further propelling the market growth.

The growing demand for animal products, such as milk, chicken, eggs, and meat, is encouraging farmers to adopt an antibiotics policy for their animals to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products that have comparatively few or no antimicrobials is also increasing rapidly. Thus, the need for healthy breeding of animals is increasing, which is expected to fuel the growth of the market.

List of Key Players of Veterinary Antimicrobial Susceptibility Testing Market

BioMérieux SA
Becton, Dickinson and Company
Synbiosis
Thermo Fisher Scientific
Bruker Corporation
Danaher Corporation
Condalab
Bioguard Corporation
Liofilchem S.r.l.
HiMedia Laboratories
Bio-Rad Laboratories
Neogen Corporation

Veterinary Antimicrobial Susceptibility Testing Market Report Highlights

By animal type, livestock animals dominated the market in 2020 due to the stringent regulatory guidelines regarding antimicrobial usage in livestock animals. Cattle accounted for over 38.0% share in 2020 due to the increasing demand for milk and the growing expenditure on livestock
The companion animal type segment is estimated to grow notably due to the increasing concerns over the transmission of resistance from companion to humans
Based on product, AST automated instruments accounted for the largest share of over 41.0% in 2020 due to its increasing adoption and higher cost. Disks and plates are expected to witness significant growth over the forecast period owing to their increased usage in labs and research institutes
In terms of end-use, in 2020, the veterinary reference lab segment held the largest share owing to its patient footfall and increased number of tests
Asia Pacific held the largest revenue share in 2020 owing to its growing livestock population and increased government initiatives

Related Reports@

Veterinary Imaging Market

Veterinary Oncology Market

Veterinary Antimicrobial Susceptibility Testing Market Segmentation

Grand View Research has segmented the global veterinary antimicrobial susceptibility testing market on the basis of animal type, product, end-use, and region:

Veterinary Antimicrobial Susceptibility Testing Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

Livestock Animals

Cattle
Poultry
Pigs
Others

Companion Animals

Cats
Dogs
Horses
Others

Veterinary Antimicrobial Susceptibility Testing Product Outlook (Revenue, USD Million, 2016 - 2028)

Disks & Plates
Culture Media
Accessories & Consumables
Automated AST Instruments

Veterinary Antimicrobial Susceptibility Testing End-use Outlook (Revenue, USD Million, 2016 - 2028)

Veterinary Reference Lab
Veterinary Research Institutes
Others

Veterinary Antimicrobial Susceptibility Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

U.S.
Canada

Europe

Germany
U.K.
France
Italy
Spain

Asia Pacific

China
India
Japan

Latin America

Brazil
Mexico

South Africa

Network Point-of-Care Glucose Testing Market Worth $1.6 Billion By 2028

The global Network Point-Of-Care Glucose Testing Market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

List of Key Players of Network Point-of-Care Glucose Testing Market

F. Hoffmann-La Roche Ltd.
Abbott
Nova Biomedical
Bayer AG/Ascensia Diabetes Care Holdings AG
Danaher

Network Point-of-Care Glucose Testing Market Report Highlights

Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring
Based on product, the Accu-Chek Inform II segment held the largest revenue share in 2020 and is expected to expand at a lucrative growth rate during the forecast period
North America held the largest revenue share in 2020 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate

Related Reports@

Point-of-Care Glucose Testing Market

Blood Glucose Monitoring Devices Market

Network Point-of-Care Glucose Testing Market Report Scope

Report Attribute	Details
Market size value in 2021	USD 1.2 billion
Revenue forecast in 2028	USD 1.6 billion
Growth Rate	CAGR of 3.9% from 2021 to 2028
Base year for estimation	2020
Historical data	2016 - 2019
Forecast period	2021 - 2028

Network Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global network point-of-care glucose testing market on the basis of product, and region:

Network Point-of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2016 - 2028)

i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus

Network Point-of-Care Glucose Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

U.S.
Canada

Europe

Germany
U.K.
France
Italy
Spain
Russia

Asia Pacific

China
Japan
India
Australia
South Korea
Thailand

Latin America

Brazil
Mexico
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Monday 24 July 2023

Personal Health Record Software Market Worth $14.9 Million By 2028

The global Personal Health Record Software Market size is expected to reach USD 14.87 million by 2028, growing at a CAGR of 9.9% over the forecast period, according to a new report by Grand View Research, Inc. High acceptance of advanced technologies, growing demand for centralizing, and streamlining of healthcare information, rising awareness among patients for medical information storage and management, and increasing government initiatives will support the market growth during the forecast period.

For instance, in October 2019, The Union Ministry of Health and Family Welfare, Government of India developed an app, ‘My Health Record’, which permits users to store their past prescriptions, detailed health profile, lab records & diagnoses at one platform and share it with medical specialists when required. The COVID-19 has toppled the way of work and life, enforcing healthcare groups to share individual’s medical records in a format that is meaningful and easily available.

The Department of Health and Human Services Office of the National Coordinator for Health Information Technology, together with the Centers for Medicare & Medicaid Services, issued two new rules to come into force in April 2021. One rule requires healthcare groups to make health record data available electronically through broadly-used technical standards. While the other forbids “information blocking,” where healthcare groups place excessive practical, cost, and technical barriers to the sharing of health information.

The North American region held the largest revenue share of over 55% in 2020 owing to the government initiatives for eHealth and an increased need to follow regulatory guidelines and curtail the rising healthcare costs. The European region held the second-largest market share in 2020 owing to the decreased cost of care and prediction of a possible medical emergency.

Key players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, in March 2020, Knapsack Health launched a free Personal Health Record for individuals, families, and caretakers.

List of Key Players of Personal Health Record (PHR) Software Market

Healthspek
Health Companion
NoMoreClipboard
Patient Ally
Records For Living, Inc.
Practice Fusion, Inc.
SoftClinic Software
Knapsack Health
75Health (Kaaspro)
Zapbuild
Validic

Related Press Release@ Personal Health Record Software Market Report

Personal Health Record Software Market Report Highlights

High acceptance of advanced technologies to cater to the growing customer needs and expansion of digital healthcare has contributed significantly to the market growth
In terms of revenue, the software & mobile apps component segment dominated the market in 2020 owing to increased supportive government initiatives
The Cloud-based deployment mode segment is expected to register the fastest CAGR over the forecast period owing to the technological up-gradation in the healthcare sector and growing focus on healthcare digitization
The standalone architecture type segment accounted for the largest revenue share in 2020 due to wide adoption on account of its benefits, such as privacy control
Key players in the personal health record software market focus on various strategies, such as new product developments and business expansions, for better market penetration
For example, in September 2020, PicnicHealth raised $25 million for its patient health record management service; thereby, strengthening its market position

Related Reports@

Electronic Health Records Market

OBGYN EHR Market

Personal Health Record Software Market Segmentation

Grand View Research has segmented the global personal health record software market on the basis of component, deployment mode, architecture type, and region:

PHR Software Component Outlook (Revenue, USD Million, 2016 - 2028)

Software & Mobile Apps
Services

PHR Software Deployment Mode Outlook (Revenue, USD Million, 2016 - 2028)

Web-based
Cloud-based

PHR Software Architecture Type Outlook (Revenue, USD Million, 2016 - 2028)

Payer Tethered
Provider Tethered
Standalone

PHR Software Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

U.S.
Canada

Europe

U.K.
Germany
France

Rest of the World

Wednesday 26 July 2023

Pneumatic Tourniquet Market Size Worth $591.6 Million By 2028

Clinical Trial Kits Market Size is Predicted to Witness 8.5% CAGR till 2028

Tuesday 25 July 2023

Veterinary Antimicrobial Susceptibility Testing Market – Industry Insights by Product And End-use

Network Point-of-Care Glucose Testing Market Worth $1.6 Billion By 2028

Network Point-of-Care Glucose Testing Market Report Scope

Monday 24 July 2023

Personal Health Record Software Market Worth $14.9 Million By 2028

Digital Pathology Market Size To Reach $1.73 Billion By 2030